It’s Final: No Medicare Coverage For Heart Transplant Rejection Test
This article was originally published in The Gray Sheet
Executive Summary
Medicare will not cover Menssana Research's Heartsbreath heart transplant rejection test, CMS said Dec. 8
You may also be interested in...
Heart Transplant Rejection Breath Test Data Falls Short – CMS
Medicare coverage of a breathalyzer test to detect heart transplant rejection is not warranted based on the current level of supporting data, CMS says
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.